ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Bristol Myers Squibb
The Senior Director, State Policy at Bristol Myers Squibb is responsible for shaping and executing the company's state policy strategy across various healthcare policy areas including Medicaid and drug pricing. The role involves leading internal and external engagement, developing policy strategies, and managing a team to promote patient access, affordability, and innovation.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
Director State Policy & Government Affairs
Regeneron Pharmaceuticals
Director, State Government Affairs
BridgeBio Pharma
Director, Federal Policy
Diversity Employment
Director, U.S. Federal and State Health Policy and Access, Rare Disease
AstraZeneca
Director, U.S. Policy – 340B Program Strategy
AbbVie
Director, U.S. Federal and State Health Policy and Access, Rare Disease
AstraZeneca